The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B
about
Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factorsInteraction of the v-Rel oncoprotein with cellular transcription factor Sp1Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisInterplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostLeucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosisThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylationUpregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator ZtaThe Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein.Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.Viral latency and its regulation: lessons from the gamma-herpesviruses.The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsEpstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 proteinModulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.NF-kappaB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein-Barr virus productive cycle by transforming growth factor beta 1NF-kappaB inhibits gammaherpesvirus lytic replicationAnalysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.Inhibition of heavy chain and beta2-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replicationYY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitorsAlteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral ReplicationFunctional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.Activation transcription factor 1 involvement in the regulation of murine H-2Dd expression.Regulation of telomerase and telomeres: human tumor viruses take control.Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.Switching of EBV cycles between latent and lytic states.Regulation of Epstein-Barr virus reactivation from latency.Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif.
P2860
Q22253362-657A9557-3776-4F1D-9935-076B72DB965AQ24645607-4D5E7F17-852E-4C3A-91E0-D042D0C16BC9Q24811971-82825ADB-4423-4371-85D0-663A53BB9726Q28079510-9A463BEC-6134-4B59-88D3-5A82BB4B5F3DQ28080198-7A8771D1-20A6-4FCD-B615-82B5F3576CF2Q28200959-12D2F4E7-43C4-4F96-A72E-D1549982698BQ28480586-BC465F90-6BEC-4F34-8705-4239B3EEC919Q33662787-DE8AE389-7A77-4CA8-9898-6AE1847555E5Q33785198-4B03EFF9-D6CE-4AB1-904F-C88DD49E13FCQ33786869-88067700-5B4A-4F45-A1D0-CB04E305CA36Q33809585-1D422724-A803-4CA4-A3B7-0A136CDE9E87Q33817111-EF7AE1EC-EBD9-4B3A-9739-75CC8FE755B1Q33898010-4909021F-CC81-492D-854C-9EADA1B815A7Q33908810-0442DB48-2C39-4C97-88CF-C8A6BB40EAC3Q33910725-3C64C4EE-0A29-4163-A9C1-40D101C89A3FQ34039189-2AA79B40-313C-4C0F-8E1E-C175F8D4CE2AQ34291099-585E30C9-BD00-450B-B8A4-F5CDB66B9208Q34301695-4CF63175-FC89-4AB0-A14C-D935DD07A335Q34589844-24D78638-6A73-4260-93B6-470E8D0DC2EDQ34606551-999702B9-318B-402D-986E-4BA2DE0E5882Q34608120-849C2B2B-258B-4DCD-8CF6-1FED20377177Q34751026-D8368A8F-D5C7-44EC-943D-D4F13EE231AEQ35077613-2CF77D8E-212A-40E2-9822-55F5552A6259Q35155154-05661024-13D0-4F03-958B-B5EF135BEAB9Q35233147-B59EC17E-6077-464B-ADCD-9233C79646D0Q35635291-B21BCC76-C622-4093-B2A4-BA7981BC625DQ35841116-CA4267D2-361F-41BE-B3AA-AB21EC43A0B3Q35851139-723354B3-034F-4C76-A5A4-C2AF2679E156Q35881137-C7555F10-77E4-4F7B-B7B4-63E57D620323Q36171933-56489356-F357-4792-84D3-921C7C36D3BDQ36363901-1E20E553-325F-44B2-9509-17E92B817B79Q36434290-D7292F05-DF08-4DB1-AEB4-3A653B995576Q36648185-7CFADAB8-E2E3-487D-9304-49BCAEB59CD1Q36668946-7941D214-EE82-44CC-B600-D1679EC2B1A6Q36866105-7EA36577-2E6D-4990-9720-9F0663D5C18AQ37053343-6CD532D4-EF60-4EED-B408-1391D8D05887Q37713982-60BF1329-64AB-4F32-97DF-69D0C476884CQ38171455-F15A1EF6-3456-4F3F-A18E-31ADF980EC83Q38208532-B0C72C0D-EA50-40E4-8707-C424C2956C01Q38296630-237C1302-2804-4F90-B869-88F1B3216E10
P2860
The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@ast
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@en
type
label
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@ast
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@en
prefLabel
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@ast
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@en
P2093
P2860
P356
P1476
The bZIP transactivator of Eps ...... the p65 subunit of NF-kappa B
@en
P2093
A S Baldwin
D E Gutsch
E A Holley-Guthrie
M A Blanar
S C Kenney
P2860
P304
P356
10.1128/MCB.14.3.1939
P407
P577
1994-03-01T00:00:00Z